Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 98 of 98 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/22
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 09/07/21
End: 01/30/24
Due: 01/30/25
Phase: N/A
Priority: Normal
Start: 06/01/16
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 02/16/17
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 06/01/16
End: 10/01/21
Due: 10/01/22
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 01/11/16
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/24/18
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 08/25/14
End: 02/28/19
Due: 02/28/20
To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
Phase: N/A
Priority: Normal
Start: 06/29/16
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 05/31/22
Due: 05/31/23
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 12/01/15
End: 06/01/18
Due: 06/01/19
Phase: N/A
Priority: Normal
Start: 10/17/22
End: 10/17/25
Due: 10/17/26
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 03/28/17
Due: 03/28/18
Phase: N/A
Priority: Normal
Start: 04/13/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/08/24
End: 10/15/24
Due: 10/15/25
Phase: N/A
Priority: Normal
Start: 05/24/19
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 05/04/21
Due: 05/04/22